MEREDITH ROWLAND: Open Payments
NPI 1538551379 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 59 payments from 20 companies in 2025. Trend: 2023 $1,147 · 2024 $1,620 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $191 |
| Amgen Inc. | 8 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Viatris Specialty LLC | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Verona Pharma, Inc. | 4 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $58 |
| Exact Sciences Corporation | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $50 |
Products named: OTEZLA, YUPELRI, Kerendia, BREZTRI, AIRSUPRA, Ohtuvayre, XIFAXAN, GVOKE HYPOPEN.
Industry payments across OK — which companies pay providers there.
